National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-HGF monoclonal antibody SCH900105
A monoclonal antibody directed against human hepatocyte growth factor (HGF) with potential antineoplastic activity. Anti-HGF monoclonal antibody SCH900105 binds to the soluble ligand HGF, preventing the binding of HGF to its receptor c-Met and activation of the HGF/c-Met signaling pathway, which may result in cell death in c-Met-expressing tumor cells. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code names:AV-299
SCH 900105



Previous:anti-EpCAM/anti-CD3 recombinant bispecific monoclonal antibody MT110, anti-ErbB3 receptor monoclonal antibody MM-121, anti-FLT-1 ribozyme, anti-GP-3 monoclonal antibody, anti-HER3 monoclonal antibody U3-1287
Next:anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968, anti-human chorionic gonadotropin vaccine, anti-IGF-1 receptor human monoclonal antibody R1507, anti-IGF-1R fully human monoclonal antibody AMG-479, anti-IGF-1R recombinant monoclonal antibody BIIB022

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov